Ghalayini Ibrahim Fathi, Al-Ghazo Mohammed A, Hani Osama Bani, Al-Azab Rami, Bani-Hani Ibrahim, Zayed Faheem, Haddad Yazan
Urology Division, King Abdullah University Hospital, Jordan University of Science and Technology, Jordan.
J Clin Med Res. 2011 May 19;3(3):124-31. doi: 10.4021/jocmr542w.
We compared the efficacy of microdissection testicular sperm extraction (microdissection TESE) and conventional TESE in patients with non-obstructive azoospermia (NOA) and related the positive sperm recovery to certain variables: follicle-stimulating hormone (FSH) and luteinizing hormone (LH) levels, testicular volume and histology.
Sperm retrieval rates (SRR) in patients with NOA who underwent microdissection TESE (n = 65) or conventional TESE (n = 68) were compared and related to the different variables.
SRR by microdissection TESE (56.9%) was significantly higher than conventional TESE (38.2%). There was a positive relation between the SRR and increased testicular volume or decreased FSH levels. No effect of Testosterone or Prolactin levels on SRR by using either technique was observed. Sperm were recovered from those with hypospermatogenesis in 84% and 92.9% by conventional and microdissection TESE, respectively (P = 0.3). In cases of maturation arrest the SRR was 27.3% and 36.4%, respectively (P = 0.6). In cases of Sertoli-cell-only syndrome (SCOS) the SRR was 6.2% and 26.9%, respectively (P = 0.03). No major operative complications occurred in any patient in either group, and no patient required post-operative hormone replacement to treat hypogonadism.
Microdissection TESE significantly had twice better probability of success of SRR when compared to conventional TESE. No secure pre-operative prognostic elements of sperm recovery exist for NOA patients. Microdissection TESE appears to be recommendable in cases of atrophied testicles, high FSH concentration, or when SCOS with high FSH concentration can be predicted.
我们比较了显微切割睾丸取精术(microdissection TESE)与传统睾丸取精术(conventional TESE)在非梗阻性无精子症(NOA)患者中的疗效,并将精子回收阳性情况与某些变量相关联:促卵泡激素(FSH)和促黄体生成素(LH)水平、睾丸体积和组织学。
比较接受显微切割睾丸取精术(n = 65)或传统睾丸取精术(n = 68)的NOA患者的精子获取率(SRR),并将其与不同变量相关联。
显微切割睾丸取精术的SRR(56.9%)显著高于传统睾丸取精术(38.2%)。SRR与睾丸体积增大或FSH水平降低呈正相关。未观察到睾酮或催乳素水平对采用任何一种技术的SRR有影响。传统睾丸取精术和显微切割睾丸取精术分别从生精功能低下患者中回收精子的比例为84%和92.9%(P = 0.3)。在成熟障碍病例中,SRR分别为27.3%和36.4%(P = 0.6)。在唯支持细胞综合征(SCOS)病例中,SRR分别为6.2%和26.9%(P = 0.03)。两组中任何患者均未发生重大手术并发症,且无患者需要术后激素替代治疗性腺功能减退。
与传统睾丸取精术相比,显微切割睾丸取精术的SRR成功概率显著高出两倍。对于NOA患者,不存在可靠的术前精子回收预后因素。在睾丸萎缩、FSH浓度高或可预测为FSH浓度高的SCOS病例中,显微切割睾丸取精术似乎是可取的。